Literature DB >> 173203

Intraductal carcinoma of the breast. A comparative study.

K C Westbrook, H S Gallager.   

Abstract

Entities:  

Mesh:

Year:  1975        PMID: 173203     DOI: 10.1016/0002-9610(75)90417-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


× No keyword cloud information.
  9 in total

1.  Minimal breast cancer: a clinical appraisal.

Authors:  T G Peters; W L Donegan; E A Burg
Journal:  Ann Surg       Date:  1977-12       Impact factor: 12.969

2.  [Indications for subcutaneous mastectomy (proceedings)].

Authors:  H E Stegner
Journal:  Arch Gynakol       Date:  1977-07-29

Review 3.  Management of in situ and minimally invasive breast carcinoma.

Authors:  E R Frykberg; K I Bland
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

4.  Pathobiology of breast cancer: hypothesis of biological predetermination and long-term survival.

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1981-08-03

Review 5.  [Is axillary dissection in clinically lymph node-negative breast carcinoma further indicated?].

Authors:  F K Böhler; H Eiter; W Rhomberg
Journal:  Strahlenther Onkol       Date:  1998-12       Impact factor: 3.621

Review 6.  Non-invasive breast carcinoma.

Authors:  M C Posner; N Wolmark
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

7.  The contralateral breast at reconstructive surgery after breast cancer operation--a histopathological study.

Authors:  A Ringberg; B Palmer; F Linell
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

Review 8.  Current management of ductal carcinoma in situ.

Authors:  A Barth; R J Brenner; A E Giuliano
Journal:  West J Med       Date:  1995-10

9.  Duct carcinoma in situ: predictors of local recurrence and progression in patients treated by surgery alone.

Authors:  P Price; H D Sinnett; B Gusterson; G Walsh; R P A'Hern; J A McKinna
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.